AXCELIS TECHNOLOGIES (ACLS)·Q4 2025 Earnings Summary

Axcelis Crushes Q4 Estimates, But Stock Plunges on Weak Q1 Guide

February 17, 2026 · by Fintool AI Agent

Axcelis Technologies (NASDAQ: ACLS) delivered a blowout Q4 2025, beating consensus estimates handily on both revenue and EPS. But investors quickly shifted focus to the Q1 2026 outlook, which came in dramatically below expectations. The stock surged 4.2% during regular trading on the initial beat headlines, only to crater 13.5% after-hours as the weak guidance sank in.

Did Axcelis Beat Earnings?

Decisively yes — but the celebration was short-lived.

The quarter was powered by record CS&I (Customer Support & Installation) revenue, which management highlighted as a key strategic win. System revenue also came in better than expected.

CEO Russell Low: "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieved another record quarter of CS&I revenue, reflecting the strength of our growing installed base and our strategic focus on driving upgrades and service contracts."

What Did Management Guide?

This is where the wheels came off. Q1 2026 guidance came in sharply below the preliminary outlook management provided in November:

The guidance implies a 52% sequential decline in Non-GAAP EPS from Q4's $1.49. This suggests the Memory recovery that management signaled in Q3 hasn't materialized as quickly as hoped, and the Power/General Mature markets remain in digestion mode.

How Did the Stock React?

The market's reaction told the story in two acts:

The initial pop reflected the Q4 beat. The aftermarket selloff reflects investor disappointment with Q1 guidance that was 9% below the preliminary outlook from just three months ago.

Notably, ACLS has now beaten Non-GAAP EPS estimates for 9 consecutive quarters, yet the stock is down ~32% from its 52-week high of $102.93.

What Changed From Last Quarter?

Memory: Still Waiting for the Inflection

In Q3, management expressed optimism about Memory improving in 2026, noting "encouraging demand trends" and expectations for DRAM/HBM investments to drive growth. The Q4 report continues this theme but with more cautious tone — Memory revenue is expected to grow in 2026, but Q1 is clearly not yet benefiting.

CS&I: The Bright Spot

CS&I continues to outperform, hitting another record in Q4. CFO Jamie Coogan highlighted: "For the full year, we delivered double-digit CS&I growth, expanded gross margins, and generated more than $100 million of free cash flow."

Veeco Merger: Still Pending

The pending all-stock merger with Veeco Instruments (announced October 2025) remains on track. Management noted: "We continue working toward closing our pending merger with Veeco and remain confident in the compelling prospects and potential of the combined company."

Transaction and integration costs of $7.5M impacted Q4 GAAP results.

Key KPIs and Segment Trends

Shipped Systems Revenue by Segment (Q4 2025)

Power (53% of Q4 shipped systems): Customers taking a disciplined approach to capacity investments given significant build-out over the past several years. One customer made a sizeable upgrade of SiC tools from 150mm to 200mm using the newly introduced Purion Power Series+ platform. Select China customers continue building SiC capacity while customers elsewhere focus on next-gen technology.

General Mature (35%): Sequential improvement in revenue led by High Current tool demand. Customers managing capacity amidst stabilizing auto and industrial demand.

Memory (9%): Growing implant demand for DRAM and HBM applications, with momentum expected to continue into 2026. Key win: Received order from leading North American memory manufacturer — an important customer expansion outside of Korea. NAND customers continue prioritizing layer count scaling over wafer capacity additions.

Advanced Logic (3%): Generated revenue from a follow-on order. Engaging with customers on next-gen needs including implant for backside power contacts and other material modification applications.

Bookings and Backlog

Bookings improved significantly on a sequential basis — up 144% from Q3's $52.2M — a positive signal for second half 2026.

Geographic Mix

China revenue declined sharply to 32% in Q4 2025 (down from 46% in Q3), reflecting digestion of prior capacity investments. This is a notable shift from FY 2024's 52% China concentration.

Balance Sheet and Capital Returns

Axcelis maintains a fortress balance sheet:

¹Q4 2025 Free Cash Flow includes ~$5M of cash transaction expenses associated with the pending Veeco merger.

Management returned more than they generated in FCF via buybacks — a signal of confidence in the balance sheet despite the cyclical downturn.

2026 Outlook by Segment

Management expects overall 2026 revenue to be relatively flat with 2025 levels, weighted to 2H 2026:

Full year 2026 non-GAAP gross margin expected in the low-to-mid 40s% range. The year-over-year decline is primarily due to higher Memory mix, plus a modest tariff impact of less than 100 basis points.

Forward Catalysts and Risks

Catalysts to Watch

1. Memory Recovery: Management expects Memory to grow in 2026 — watch for greenfield capacity announcements from DRAM/HBM customers. North American memory customer win expands footprint outside Korea
2. Veeco Merger Closing: Expected to create a broader semiconductor equipment platform
3. Silicon Carbide Design Wins: Growing interest in proprietary High Energy channeling capabilities for deep implants such as SiC superjunction development
4. Bookings Recovery: Q4 bookings of $127.6M (up 144% sequentially) suggest improving order momentum

Key Risks

1. Guidance Credibility: Q1 guidance is 9% below November's preliminary view — raises questions about visibility
2. Tariff Exposure: Management expects tariff impact of less than 100 basis points on 2026 gross margins — modest but notable
3. General Mature Weakness: Auto, industrial, consumer markets remain in digestion mode
4. China Concentration: Declining but still significant — dropped to 32% in Q4 from 46% in Q3, but FY 2025 average was 42%; policy risk remains
5. Backlog Decline: Systems backlog of $457M is down 29% YoY from $645.8M, reflecting the cyclical downturn

The Bottom Line

Axcelis delivered exactly what investors want in a quarter: big beats on revenue (+11%) and EPS (+33%), record CS&I, and strong free cash flow. But the Q1 2026 guidance reset overshadowed everything. Revenue guidance of $195M vs the November preliminary outlook of $215M suggests either (1) Memory isn't recovering as fast as hoped, (2) Power/Mature weakness is worse than expected, or (3) management was too optimistic three months ago.

For long-term holders, the thesis remains intact: dominant position in high-energy ion implantation for silicon carbide, growing CS&I base, and an accretive merger pending. But the path to getting paid has gotten bumpier. With the stock now down ~10% from yesterday and trading at depressed levels, the debate shifts to whether this guidance cut is a buying opportunity or a warning sign of more resets to come.

---

View ACLS Research | Q4 2025 Earnings Transcript | Prior Quarter: Q3 2025